{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:26:40Z","timestamp":1761989200143},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peritoneal fibrosis (PS) determines the long-term outcome of peritoneal dialysis (PD). We previous confirmed that hydrogen sulfide (H<jats:sub>2<\/jats:sub>S) inhibited PS, but its cellular mechanism was not fully elucidated. Epithelial-mesenchymal transition (EMT) of mesothelial cells (MCs) is an important cellular event of PS, we therefore investigated whether EMT can be affected by H<jats:sub>2<\/jats:sub>S in MCs. Rats were treated with 4.25% -glucose PD fluids plus lipopolysaccharide for 28 days to produce PS, and NaHS (56\u2009\u03bcg\/kg.d) was given simultaneously. NaHS (56\u2009\u03bcg\/kg.d) reduced the deposition of collagen in the submesothelial zone compared with the PS group. In primarily cultured rat MCs, 4.25% -glucose PD fluid induced EMT in MCs featured as loss of ZO-1 and Cytokeratin, and increase of \u03b1-SMA, plasminogen activator inhibitor 1, fibronectin and TGF-\u03b21 proteins. PD fluid also increased IL-6 and monocyte chemotactic protein-1 mRNA expressions as well as the phosphorylation of Smad2\/3 and Smad3. NaHS (50\u2013300\u2009\u03bcmol\/L) reversed the above alterations with the optimal dose at 100\u2009\u03bcmol\/L. Thus, exogenous H<jats:sub>2<\/jats:sub>S improves PS by inhibiting EMT in MCs. The anti-EMT effect of H<jats:sub>2<\/jats:sub>S is associated with the inhibition of inflammation and TGF-\u03b21-Smad signal pathway.<\/jats:p>","DOI":"10.1038\/s41598-018-21807-x","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T14:37:53Z","timestamp":1523457473000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hydrogen sulfide inhibits epithelial-mesenchymal transition in peritoneal mesothelial cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Shengnan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"21807_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ki.1990.231","volume":"38","author":"O Heimburger","year":"1990","unstructured":"Heimburger, O. et al. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney international 38, 495\u2013506 (1990).","journal-title":"Kidney international"},{"key":"21807_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1681\/ASN.2009070694","volume":"21","author":"O Devuyst","year":"2010","unstructured":"Devuyst, O., Margetts, P. J. & Topley, N. The pathophysiology of the peritoneal membrane. Journal of the American Society of Nephrology: JASN 21, 1077\u20131085 (2010).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"21807_CR3","doi-asserted-by":"publisher","first-page":"8801","DOI":"10.1073\/pnas.1206646109","volume":"109","author":"R Wang","year":"2012","unstructured":"Wang, R. Shared signaling pathways among gasotransmitters. Proceedings of the National Academy of Sciences of the United States of America 109, 8801\u20138802 (2012).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"21807_CR4","first-page":"458720","volume":"2015","author":"K Song","year":"2015","unstructured":"Song, K. et al. Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease? Oxidative medicine and cellular longevity 2015, 458720 (2015).","journal-title":"Oxidative medicine and cellular longevity"},{"key":"21807_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000441504","volume":"131","author":"Y Lu","year":"2015","unstructured":"Lu, Y. et al. Hydrogen Sulfide Alleviates Peritoneal Fibrosis via Attenuating Inflammation and TGF-beta1 Synthesis. Nephron 131, 210\u2013219 (2015).","journal-title":"Nephron"},{"key":"21807_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa020809","volume":"348","author":"M Yanez-Mo","year":"2003","unstructured":"Yanez-Mo, M. et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. The New England journal of medicine 348, 403\u2013413 (2003).","journal-title":"The New England journal of medicine"},{"key":"21807_CR7","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1681\/ASN.2013101079","volume":"25","author":"YT Chen","year":"2014","unstructured":"Chen, Y. T. et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. Journal of the American Society of Nephrology: JASN 25, 2847\u20132858 (2014).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"21807_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1681\/ASN.2004060436","volume":"16","author":"PJ Margetts","year":"2005","unstructured":"Margetts, P. J. et al. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. Journal of the American Society of Nephrology: JASN 16, 425\u2013436 (2005).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"21807_CR9","doi-asserted-by":"crossref","unstructured":"Del Peso, G et al. Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney international Supplement\n                           : S26\u201333 (2008).","DOI":"10.1038\/sj.ki.5002598"},{"key":"21807_CR10","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nm888","volume":"9","author":"M Zeisberg","year":"2003","unstructured":"Zeisberg, M. et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature medicine 9, 964\u2013968 (2003).","journal-title":"Nature medicine"},{"issue":"Suppl 2","key":"21807_CR11","doi-asserted-by":"publisher","first-page":"ii2","DOI":"10.1093\/ndt\/gfl183","volume":"21","author":"R Selgas","year":"2006","unstructured":"Selgas, R. et al. Epithelial-to-mesenchymal transition of the mesothelial cell\u2013its role in the response of the peritoneum to dialysis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 21(Suppl 2), ii2\u20137 (2006).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"21807_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.tips.2007.09.003","volume":"28","author":"JL Wallace","year":"2007","unstructured":"Wallace, J. L. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends in pharmacological sciences 28, 501\u2013505 (2007).","journal-title":"Trends in pharmacological sciences"},{"key":"21807_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1053\/j.gastro.2006.02.033","volume":"131","author":"S Fiorucci","year":"2006","unstructured":"Fiorucci, S. et al. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 131, 259\u2013271 (2006).","journal-title":"Gastroenterology"},{"key":"21807_CR14","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/ki.2013.449","volume":"85","author":"K Song","year":"2014","unstructured":"Song, K. et al. Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy. Kidney international 85, 1318\u20131329 (2014).","journal-title":"Kidney international"},{"key":"21807_CR15","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.3892\/mmr.2016.5744","volume":"14","author":"S Shi","year":"2016","unstructured":"Shi, S. et al. Molecular mechanisms of melatonin in the reversal of LPS-induced EMT in peritoneal mesothelial cells. Molecular medicine reports 14, 4342\u20134348 (2016).","journal-title":"Molecular medicine reports"},{"key":"21807_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/ars.2011.4351","volume":"17","author":"JL Wallace","year":"2012","unstructured":"Wallace, J. L., Ferraz, J. G. & Muscara, M. N. Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxidants & redox signaling 17, 58\u201367 (2012).","journal-title":"Antioxidants & redox signaling"},{"key":"21807_CR17","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1083\/jcb.127.6.2021","volume":"127","author":"PJ Miettinen","year":"1994","unstructured":"Miettinen, P. J. et al. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. The Journal of cell biology 127, 2021\u20132036 (1994).","journal-title":"The Journal of cell biology"},{"key":"21807_CR18","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1046\/j.1523-1755.1999.00656.x","volume":"56","author":"JM Fan","year":"1999","unstructured":"Fan, J. M. et al. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney international 56, 1455\u20131467 (1999).","journal-title":"Kidney international"},{"key":"21807_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-56","volume":"6","author":"H Kasai","year":"2005","unstructured":"Kasai, H. et al. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respiratory research 6, 56 (2005).","journal-title":"Respiratory research"},{"key":"21807_CR20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajpath.2013.05.019","volume":"183","author":"Q Zhou","year":"2013","unstructured":"Zhou, Q. et al. miR-30a negatively regulates TGF-beta1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1. The American journal of pathology 183, 808\u2013819 (2013).","journal-title":"The American journal of pathology"},{"issue":"Suppl 3","key":"21807_CR21","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1177\/089686080802803s18","volume":"28","author":"Q Liu","year":"2008","unstructured":"Liu, Q. et al. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells. Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis 28(Suppl 3), S88\u201395 (2008).","journal-title":"Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21807-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:21:45Z","timestamp":1671596505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21807-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21807"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21807-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"10 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5863"}}